SLC25A3 negatively regulates NLRP3 inflammasome activation by restricting the function of NLRP3.

J Biol Chem

Hubei Key Laboratory of Cognitive and Affective Disorders, Institute of Biomedical Sciences, School of Medicine, Jianghan University, Wuhan, China; Foshan Institute of Medical Microbiology, Foshan, China. Electronic address:

Published: May 2024

AI Article Synopsis

  • NLRP3 inflammasome is crucial for the immune response but can cause inflammation and tissue damage if overactivated, necessitating careful regulation.
  • SLC25A3, a mitochondrial phosphate carrier, has been identified as a key negative regulator of NLRP3 inflammasome activation through its interaction with NLRP3.
  • The binding of SLC25A3 to NLRP3 disrupts the NLRP3-NEK7 interaction, leading to the ubiquitination of NLRP3, providing insights for potential treatments of diseases related to NLRP3 inflammasome activation.

Article Abstract

The NACHT, leucine-rich repeat, and pyrin domains-containing protein 3 (collectively known as NLRP3) inflammasome activation plays a critical role in innate immune and pathogenic microorganism infections. However, excessive activation of NLRP3 inflammasome will lead to cellular inflammation and tissue damage, and naturally it must be precisely controlled in the host. Here, we discovered that solute carrier family 25 member 3 (SLC25A3), a mitochondrial phosphate carrier protein, plays an important role in negatively regulating NLRP3 inflammasome activation. We found that SLC25A3 could interact with NLRP3, overexpression of SLC25A3 and knockdown of SLC25A3 could regulate NLRP3 inflammasome activation, and the interaction of NLRP3 and SLC25A3 is significantly boosted in the mitochondria when the NLRP3 inflammasome is activated. Our detailed investigation demonstrated that the interaction between NLRP3 and SLC25A3 disrupted the interaction of NLRP3-NEK7, promoted ubiquitination of NLRP3, and negatively regulated NLRP3 inflammasome activation. Thus, these findings uncovered a new regulatory mechanism of NLRP3 inflammasome activation, which provides a new perspective for the therapy of NLRP3 inflammasome-associated inflammatory diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11067542PMC
http://dx.doi.org/10.1016/j.jbc.2024.107233DOI Listing

Publication Analysis

Top Keywords

nlrp3 inflammasome
32
inflammasome activation
24
nlrp3
14
inflammasome
8
interaction nlrp3
8
nlrp3 slc25a3
8
slc25a3
7
activation
7
slc25a3 negatively
4
negatively regulates
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!